| Sep 24, 2026 |
Walbert Keli |
COAG Hemab Therapeutics Holdings, Inc. |
OTHER |
36,000 |
N/A |
| Jun 16, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
61,523 |
$1.5M |
| Jun 15, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
6,146 |
$153K |
| May 20, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
996 |
$25K |
| May 19, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
3,802 |
$95K |
| May 12, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
6,387 |
$159K |
| May 11, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
25,720 |
$643K |
| May 11, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
14,149 |
$346K |
| May 8, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
1,483 |
$37K |
| May 7, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
1,985 |
$50K |
| May 7, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
7,921 |
$193K |
| May 4, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
OTHER |
10,054 |
N/A |
| May 4, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
OTHER |
56,972 |
N/A |
| May 4, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
OTHER |
18,146 |
N/A |
| May 4, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
OTHER |
42,341 |
N/A |
| May 4, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
OTHER |
27,720 |
N/A |
| May 4, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
OTHER |
64,680 |
N/A |
| May 6, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
53,407 |
$1.3M |
| May 6, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
14,611 |
$347K |
| May 5, 2026 |
RA CAPITAL MANAGEMENT, L.P. |
COAG Hemab Therapeutics Holdings, Inc. |
BUY |
10,268 |
$257K |